Fundraising Fox
/People
Sign in

Kenneth Grisé

Investor

Principal at Sixty Degree Capital

Toronto, Ontario

Writes $100K – $5M checks · typically $1.5M

Find your path to Kenneth

319 people in our graph can introduce you to Kenneth.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Alex Mayweg to introduce you to Kenneth

You →Alex · together at Red Ridge Bio (2023) →Kenneth

Ask Jamie Chen to introduce you to Kenneth

You →Jamie · together at Crossbow Therapeutics →Kenneth

Ask Sam Okafor to introduce you to Kenneth

You →Sam · 7 people · together at Sixty Degree Capital →Kenneth

Sign up to find every way you can get introduced to Kenneth

  • Your email: the people you already email who know Kenneth
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Kenneth
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Principal serving as a science and market expert for the biotech and healthcare portfolio, joining in 2021. Formerly in drug discovery and regenerative medicine; holds a PhD in molecular genetics from the University of Toronto.

Experience

  1. Sixty Degree CapitalPrincipal, Healthcare Investmentscurrent2024 — present
  2. Sixty Degree CapitalAssociate, Healthcare Investments2021 — 2024Toronto, Ontario, Canada
  3. BOLD Longevity Growth FundBoard Observercurrent2025 — present
  4. Google for StartupsMentor - Google for Startups Accelerator: Canadacurrent2024 — present
  5. Ken Grisé Science ConsultingScientific Consultantcurrent2013 — present
  6. Alveus Therapeutics IncInvestor2026
  7. Seawolf Therapeutics, Inc.Investor2025
  8. Kinaset TherapeuticsInvestor2025
  9. Crossbow Therapeutics, IncInvestor2025
  10. knownwellInvestor2025
  11. AAVantgardeInvestor2025
  12. Parabilis MedicinesInvestor2024
  13. GlycoEra AGInvestor2024
  14. Nested TherapeuticsInvestor2024
  15. Strive HealthInvestor2023
  16. NextPoint Therapeutics, Inc.Investor2023
  17. Red Ridge BioInvestor2023
  18. Vivid Foundry Corp.Scientific Consultant2019 — 2023Toronto, Ontario, Canada
  19. Everside HealthInvestor2022
  20. RefleXion MedicalInvestor2022
  21. Korro Bio, Inc.Investor2022
  22. TransThera | 药捷安康Investor2021
  23. Turnstone BiologicsInvestor2021
  24. Bionaut LabsInvestor2021
  25. T-knife TherapeuticsInvestor2021
  26. Endogena Therapeutics, Inc.Scientist - Academic-Industry Partnership2016 — 2020Toronto, Ontario, Canada
  27. University of TorontoTeaching Assistant2013 — 2018Toronto, Canada Area
  28. University of TorontoHead Teaching Assistant - General and Human Genetics (HMB265)2016 — 2017
  29. University of TorontoGuest Lecturer2015 — 2016Toronto, Canada Area
  30. UbisoftScientific Consultant2015 — 2016
  31. CCRMScientific Consultant2013 — 2014Toronto, Ontario, Canada
  32. Western UniversityTeaching Assistant2010 — 2012London, Canada Area
  33. Western UniversityResearch Assistant / Work-Study Student2009 — 2010London, Canada Area
  34. Sernova Corp.Intern / Research Assistant2007 — 2008London, Ontario, Canada

Skills & more

Research14Science13Data Analysis10Western Blotting11Microscopy7Tissue Culture4Teaching6Cell Culture13Scientific Writing16Biochemistry9Microbiology5Research Design4
+5 moreELISAFluorescence MicroscopyHistologyGeneticsMolecular Biology

Languages Basic French · English

  • MBA Essentials — University of Toronto - Rotman School of Management
  • Foundations of Project Management - I — Mitacs
  • Entrepreneurship 101 — MaRS Discovery District

From Kenneth's professional profile.

Colleagues at Sixty Degree Capital

Atia Roche-Nagle
Director of Investor Relations at Sixty Degree Capital
Brett Liu
Principal at Sixty Degree Capital
Cheryl Kuai
Managing Director at Sixty Degree Capital
Hoyin Lip
Associate at Sixty Degree Capital
Hoyin Yip
Associate at Sixty Degree Capital
Jenny Lo
Principal at Sixty Degree Capital
Jojo Ye
Associate at Sixty Degree Capital
Lillian Yu
Analyst, Fund Operations at Sixty Degree Capital

Network1

Cheryl Kuai
Managing Director at Sixty Degree Capital

Investors connected to Kenneth in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kenneth Grisé?
Principal serving as a science and market expert for the biotech and healthcare portfolio, joining in 2021. Formerly in drug discovery and regenerative medicine; holds a PhD in molecular genetics from the University of Toronto.
Where does Kenneth Grisé work?
Kenneth Grisé is Principal at Sixty Degree Capital.
What check size does Kenneth Grisé write?
Kenneth Grisé typically writes checks of $100K – $5M.
Where did Kenneth Grisé go to school?
Kenneth Grisé studied at University of Toronto (Doctor of Philosophy (Ph.D.), Molecular Genetics / Stem Cells / Neurobiology); Western University (Master of Science (M.Sc.), Kinesiology/Integrative Physiology); Western University (Honours BSc, Physiology and Psychology).

Same school

Shared employers